Medicare Enrolled

Dr. David Holck, M.D.

Ophthalmic Plastic and Reconstructive Surgery Physician · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1314 E SONTERRA BLVD STE 5104, San Antonio, TX 78258
2104952367
In practice since 2007 (19 years)
NPI: 1548319601 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holck? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holck

Dr. David Holck is an ophthalmic plastic and reconstructive surgery physician in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Holck performed 17,276 Medicare services across 5,018 unique beneficiaries.

Between the years covered by Open Payments, Dr. Holck received a total of $6,541 from 25 pharmaceutical and/or device companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmic plastic and reconstructive surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holck is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 5% volume in TX$ $6,541 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,276
Medicare services
Top 5% in TX for ophthalmic plastic and reconstructive surgery physician
5,018
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~909 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit11,370$5$13
Photography of content of eyes1,562$17$66
Probing of nasal tear duct1,165$146$381
New patient office visit (45-59 min)654$115$323
Office visit, established patient (20-29 min)520$63$176
Exam of visual field with intermediate testing389$36$91
Office visit, established patient (30-39 min)230$89$248
Repair of tendon of upper eyelid173$618$1,643
Removal of growth of eyelid135$176$545
Comprehensive eye exam, established patient125$86$245
Removal of over 1/4 of eyelid margin and repair of eyelid107$469$1,343
Injection of chemical for paralysis of nerve muscles on side of face98$140$379
Repair of brow paralysis84$292$1,435
Temporary closure of eyelids by suture73$36$184
Probing of nasal tear duct with insertion of tube or stent69$93$464
Plastic repair of tear duct58$348$1,267
Extensive repair of turning-outward eyelid defect42$321$1,316
Repair of eyelid lining with graft from external eye39$221$1,089
Exploration of cavity behind eye36$986$2,460
Injection into skin growth, 1-7 growths32$26$111
Visual field test, extended31$49$121
Steroid injection (triamcinolone)31$1$6
Comprehensive eye exam, new patient28$103$291
Suture repair of turning-inward eyelid defect27$129$643
Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less25$641$1,632
Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less21$544$1,496
Exam of visual field with limited testing19$23$64
New patient office visit (30-44 min)19$63$217
Therapeutic fracture of nasal passages18$46$231
Incision and drainage of abscess of eyelid18$203$552
Correction of widely-opened upper eyelid16$234$1,072
New patient problem focused exam of visual system13$65$166
Eye exam, established patient, focused13$65$174
Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm12$424$1,585
Partial removal of nasal sinus12$246$1,224
Creation of drainage tract from tear sac to nasal cavity12$524$1,569
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
66.7% medium
32.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,541
Total received (2018-2024)
Avg $934/year across 7 years
Top 7% in TX for ophthalmic plastic and reconstructive surgery physician
25
Companies
161
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,710 (72.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,830 (28.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,179
2023
$962
2022
$2,472
2021
$577
2020
$244
2019
$245
2018
$862

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Horizon Therapeutics plc
$2,657
Amgen Inc.
$650
ABBVIE INC.
$648
TissueTech, Inc.
$321
Mallinckrodt LLC
$276
Bausch & Lomb, a division of Bausch Health US, LLC
$200
BIOTISSUE HOLDINGS INC.
$184
BIOTISSUE HOLDINGS, INC.
$176
Alcon Vision LLC
$150
Genentech USA, Inc.
$130
BioTissue Holdings, Inc.
$128
Allergan, Inc.
$126
Eyevance Pharmaceuticals LLC
$125
Dompe US, Inc.
$122
Ocular Therapeutix, Inc.
$107
RxSight Inc
$101
Alcon Laboratories Inc
$100
Aerie Pharmaceuticals, Inc.
$98
Merz Pharmaceuticals, LLC
$90
Merz North America, Inc.
$67
Boston Scientific Corporation
$31
TISSUETECH, INC.
$15
Galderma Laboratories, L.P.
$14
Allergan Inc.
$13
Kerecis Limited
$10
Top 3 companies account for 60.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · BOTOX · Clareon · DEXTENZA · DURYSTA · Kerecis Omega3 SurgiClose · Lucentis · OXERVATE · PROKERA · PROLENSA · Prokera · RXSIGHT CONTACT LENS · TEPEZZA · Tobradex ST · VYZULTA · WaveWriter Alpha Prime 16 · XEOMIN · Xeomin · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (72%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for ophthalmic plastic and reconstructive surgery physician in TX.

Equivalent to $38 per 100 Medicare services performed
Looking for a ophthalmic plastic and reconstructive surgery physician in San Antonio?
Compare ophthalmic plastic and reconstructive surgery physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse ophthalmic plastic and reconstructive surgery physicians nearby

Geographic Context

Ophthalmic Plastic and Reconstructive Surgery Physicians within 10 mi
7
Per 100K population
0.3
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Holck is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 7%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Holck experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Holck performed 11,370 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Holck receive payments from pharmaceutical companies?
Yes. Dr. Holck received a total of $6,541 from 25 companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holck's costs compare to other ophthalmic plastic and reconstructive surgery physicians in San Antonio?
Dr. Holck's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →